The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bayer
Prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer (SWOG S0800) using image analysis-based tumor infiltrating lymphocyte measurements.
 
Kim Blenman
Other Relationship - CDI Laboratories
 
Kristina Fanucci
No Relationships to Disclose
 
Yalai Bai
No Relationships to Disclose
 
Vasiliki Pelekanou
No Relationships to Disclose
 
Zeina A. Nahleh
No Relationships to Disclose
 
Saba Shafi
No Relationships to Disclose
 
Sneha Burela
No Relationships to Disclose
 
William E. Barlow
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Priyanka Sharma
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Genzyme; Gilead Sciences; Gilead Sciences; GlaxoSmithKline; Merck; Novartis; Pfizer; Sanofi; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Cosmo Biosciences (I); Gilead Sciences; Merck (Inst); Novartis; Novartis (Inst)
Travel, Accommodations, Expenses - Seagen
 
Alastair Mark Thompson
Employment - Lilly (I)
Stock and Other Ownership Interests - Lilly (I)
 
Andrew K. Godwin
Stock and Other Ownership Interests - Clara Biotech
Honoraria - Sinochips Kansas
Consulting or Advisory Role - Biovica
Research Funding - BioFluidica (Inst); Clara Biotech (Inst); Predicine (Inst); VITRAC Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Provisional Patent application entitled - "WJMSC-Derived Small Extracellular Vesicle (sEVs) Enhance T Cell Suppression Through Checkpoint PD-L1" - Dr. Joseph McGuirk (applicant) (Inst)
 
David L. Rimm
Stock and Other Ownership Interests - Pixel Gear
Honoraria - Amgen
Consulting or Advisory Role - AstraZeneca; Cell Signaling Technology; Cepheid; Daiichi Sankyo; Danaher; GlaxoSmithKline; Konica Minolta; Merck; NanoString Technologies; NextCure; PAIGE.AI; Regeneron; Roche; Sanofi; Verily
Research Funding - Amgen (Inst); Cepheid (Inst); Konica Minolta (Inst); Navigate Biopharma (Inst); NextCure (Inst)
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Expert Testimony - Bryan Cave Leighton Paisner
 
Gabriel N. Hortobagyi
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Lajos Pusztai
Honoraria - Athenex; bioTheranostics; natera; OncoCyte
Consulting or Advisory Role - Almac Diagnostics; AstraZeneca; Bristol Myers Squibb; Clovis Oncology; Eisai; H3 Biomedicine; Immunomedics; Merck; Novartis; Pfizer; Roche/Genentech; Seagen; Syndax
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine; NanoString Technologies